Report #2840591

Received May 12, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 42 yrs
State: AZ
Recovered: Recovered
Vaccinated: Mar 18, 2025
Onset: Mar 18, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
SMALLMNK	SMALLPOX + MONKEYPOX (JYNNEOS)	BAVARIAN NORDIC	1	96867	IM / RA

Symptoms (1)

No adverse event

Symptom narrative

The treatment was the first of a two-series vaccination. The outcome was uneventful, with no symptoms or signs of reactions reported.

Current illness

None reported

Medical history

HIV infection, asymptomatic Preventative health care Depression Anxiety Status post hip surgery History of cervical spine fracture Bipolar disorder ADD (attention deficit disorder) Alcohol use disorder, moderate, dependence Methamphetamine use disorder, moderate, in early remission Onychomycosis Elevated ETOH level Erectile dysfunction Tobacco dependence COVID-19 vaccination declined Syphilis Need for prophylactic vaccination against smallpox

Other medications

QUEtiapine (SEROQUEL XR) 400 mg XR tablet bictegrav-emtricit-tenofov (BIKTARVY) 50-200-25 mg tab docosanoL (ABREVA) 10 % cream fexofenadine (ALLERGY RELIEF, FEXOFENADINE,) 180 mg tab albuterol HFA (PROAIR, PROVENTIL OR VENTOLIN HFA) 90 mcg/

Allergies

NKDA

Lab data

N/A